Aura Muntasell
12PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jan 07, 2026
The CD94/NKG2A-HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective.Miguel López-Botet, Carlos Vilches, Aura Muntasell
|Mar 22, 2025
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression.Anna Rea, Sara Santana-Hernández, Javier Villanueva
|Jan 03, 2024
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.Sara Santana-Hernández, Jesús Suarez-Olmos, Sonia Servitja
|Apr 19, 2022
Characterization of KIR+ NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-C.Raffaella Meazza, Michela Falco, Paolo Canevali
|Apr 12, 2022
Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.Michela Falco, Raffaella Meazza, Claudia Alicata
|Sep 28, 2021
CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function.Mariona Cabo, Sara Santana-Hernández, Marcel Costa-Garcia
Pageof 2
Frequent Collaborators
10 joint publications
Miguel López-Botet
2 joint publications
Lorenzo Moretta
2 joint publications
Raffaella Meazza
2 joint publications
Daniela Pende
2 joint publications
Paolo Canevali
2 joint publications
Sara Santana-Hernández
2 joint publications
Michela Falco
2 joint publications
Anna Rea
2 joint publications
Manel Juan
1 joint publications
Carlos Vilches
